Authors: Wartiovaara, U Mikkola, H Szoke, G Haramura, G Karpati, L Balogh, I Lassila, R Muszbek, L Palotie, A

Citation: U. Wartiovaara et al., Effect of Va134Leu polymorphism on the activation of the coagulation factor XIII-A, THROMB HAEM, 84(4), 2000, pp. 595-600

Authors: Mikkelsson, J Perola, M Wartiovaara, U Peltonen, L Palotie, A Penttila, A Karhunen, PJ

Citation: J. Mikkelsson et al., Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly, THROMB HAEM, 84(1), 2000, pp. 78-82

Authors: Balogh, I Szoke, G Karpati, L Wartiovaara, U Katona, E Komaromi, I Haramura, G Pfliegler, G Mikkola, H Muszbek, L

Citation: I. Balogh et al., Va134Leu polymorphism of plasma factor XIII: biochemistry and epidemiologyin familial thrombophilia, BLOOD, 96(7), 2000, pp. 2479-2486

Authors: Helio, T Wartiovaara, U Halme, L Turunen, UM Mikkola, H Palotie, A Farkkila, M Kontula, K

Citation: T. Helio et al., Arg506Gln factor V mutation and Val34Leu factor XIII polymorphism in Finnish patients with inflammatory bowel disease, SC J GASTR, 34(2), 1999, pp. 170-174

Authors: Wartiovaara, U Perola, M Mikkola, H Totterman, K Savolainen, V Penttila, A Grant, PJ Tikkanen, MJ Vartiainen, E Karhunen, PJ Peltonen, L Palotie, A

Citation: U. Wartiovaara et al., Association of FXIII Val34Leu with decreased risk of myocardial infarctionin Finnish males, ATHEROSCLER, 142(2), 1999, pp. 295-300